🔴 CTXR is trading 5% down today as it pulls back from a recent multi-day bounce

CTXR is trading 5% down at $0.58 in pre-market, pulling back after a recent multi-day bounce from the mid-$0.50s.

• No fresh earnings, FDA, financing, or M&A headlines have been released since the May 15, 2026, fiscal Q2 report and LYMPHIR/financing update.
• The move appears to be routine volatility common in low-priced biotech stocks rather than a reaction to new company-specific news.